Article

ERCC1-XPF Interacts with Topoisomerase IIβ to Facilitate the Repair of Activity-induced…

medRxiv · 2020 · Chatzinikolaou, G.; Stratigi, K.; Agathangelou, K.; Tsekrekou, M.; Goulielmaki, E.; Chatzidoukaki, O.; Gkirtzimanaki, K.; Aid-Pavlidis, T.; Aivaliotis, M.; Pavlidis, P.; Tsamardinos, I.; Topalis, P.; Bouwman, B. A. M.; Crosetto, N.; Altmueller, J.; Garinis, G. A.

Key facts

Title ERCC1-XPF Interacts with Topoisomerase IIβ to Facilitate the Repair of Activity-induced DNA Breaks
First author Chatzinikolaou, G.; Stratigi, K.; Agathangelou, K.; Tsekrekou, M.; Goulielmaki, E.; Chatzidoukaki, O.; Gkirtzimanaki, K.; Aid-Pavlidis, T.; Aivaliotis, M.; Pavlidis, P.; Tsamardinos, I.; Topalis, P.; Bouwman, B. A. M.; Crosetto, N.; Altmueller, J.; Garinis, G. A.
Journal medRxiv
Published Jan 3, 2020
DOI 10.1101/2020.01.03.892703
Devices mentioned K073490, K800781, K802418, K940737
Product codes mentioned CFN, KIS, PFF, PFT

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature